Isoniazid dry powder inhalant for treating pulmonary tuberculosis

A dry powder inhaler and isoniazid technology, which is applied in powder delivery, medical preparations containing no active ingredients, medical preparations containing active ingredients, etc., can solve the problem of low drug loading, large amount of excipients, and reduced drug loading to achieve high drug delivery rate, simple preparation process, and high formulation stability
CN112336703AActive Publication Date: 2021-02-09SHENZHEN SCIENCARE MEDICAL INDUSTRIES CO. LTD.
4 Cites 4 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SHENZHEN SCIENCARE MEDICAL INDUSTRIES CO. LTD.
Publication Date
2021-02-09

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to an isoniazid dry powder inhalant for treating pulmonary tuberculosis. The isoniazid dry powder inhalant comprises isoniazid micro-powder and comprises or does not comprise carrier micro-powder; the particle size of the isoniazid micro-powder is treated to 0.1-10 mu m by a fluidized bed supersonic jet milling method or a spray drying method; preferably, auxiliary materialsincluding leucine, mannitol or phospholipid are added into the dry powder inhalant so as to enhance the pelletizing rate of particles; and furthermore, auxiliary materials including magnesium stearate, mannitol, leucine and / or lactose are added so as to improve the flowability of the medicine and reduce the particle agglomeration phenomenon. The preparation process of the isoniazid dry powder inhalant is simple; and the isoniazid dry powder inhalant with relatively high stability can be prepared. The dry powder inhalant can effectively deliver drugs to pulmonary alveoli so as to effectively kill and inhibit tubercle bacillus in respiratory tracts, and is particularly suitable for treating pulmonary tuberculosis patients with impaired liver functions.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to an isoniazid dry powder inhaler for treating pulmonary tuberculosis and a preparation method thereof, as well as its use in preparing medicines for treating various types of pulmonary tuberculosis. Background technique

[0002] Tuberculosis is a highly contagious lung disease, which is very destructive to the lungs, and the treatment takes a long time, usually more than half a year. The current clinical treatment of pulmonary tuberculosis often adopts oral quadruple therapy of isoniazid, rifampicin, ethambutol and pyrazinamide. Among them, isoniazid has strong antibacterial activity against Mycobacterium tuberculosis, and is a very effective and rapid Mycobacterium tuberculosis fungicide. The effective concentration is 0.3-10 μg / mL, which can achieve very good antibacterial and bactericidal effects. However, conventional oral preparations have strong hepato...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More